Monogram is a leader in developing and commercializing innovative products to
help guide and improve the treatment of infectious diseases, cancer and other
serious diseases. Our molecular diagnostics and testing services enable:
- Healthcare providers to optimize treatment regimens for their patients to lead
to better outcomes and reduced costs by matching the underlying molecular
elements of an individual patient's disease to the drug best able to affect
those elements; and
- Pharmaceutical companies to develop new and improved antiviral therapeutics and
vaccines as well as targeted cancer therapeutics more efficiently by providing
enhanced patient selection and monitoring capabilities throughout the
We have developed HIV tests, or assays, to help make the complexities of
antiretroviral therapy easier to manage.
We have also developed oncology products to help accelerate the development of
targeted cancer therapeutics.